(Q39481269)

12 September 2017

ID4 is frequently downregulated and partially hypermethylated in prostate cancer (English)

1 reference

12 September 2017

1 reference

1 reference

4

1 reference

12 September 2017

Anna Vinarskaja

1

1 reference

12 September 2017

Wolfgang Goering

series ordinal

2

1 reference

12 September 2017

Marc Ingenwerth

series ordinal

3

1 reference

12 September 2017

language of work or name

1 reference

1 September 2011

1 reference

12 September 2017

World Journal of Urology

1 reference

12 September 2017

30

1 reference

12 September 2017

319-325

1 reference

12 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s00345-011-0750-8

12 September 2017

0 references

cites work

The power and the promise of DNA methylation markers

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Epigenetic mechanisms in the biology of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

DNA methylation changes in prostate cancer: current developments and future clinical implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Methods for detecting DNA methylation in tumors: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Id proteins at the cross-road of development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Id proteins in cell cycle control and cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Id proteins expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Cancer DNA methylation: molecular mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Quantitative, spatial resolution of the epigenetic field effect in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Gene promoter methylation and its potential relevance in early prostate cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

Evidence for field cancerization of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0750-8

ID4: a new player in the cancer arena

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21882048

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Protein phosphatase and TRAIL receptor genes as new candidate tumor genes on chromosome 8p in prostate cancer.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21882048

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Differential gene expression in tumor adjacent histologically normal prostatic tissue indicates field cancerization.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21882048

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00345-011-0750-8

1 reference

12 September 2017

1 reference